INTEGRA LIFESCIENCES HOLDINGS CORP Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -30.90% for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-26.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2018-04-26
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for the quarter ending 2018-03-31 was -30.90%.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for the quarter ending 2017-03-31 was -57.70%.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2017 was -57.90%.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2016 was -3.90%.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2015 was 0.00%.
- INTEGRA LIFESCIENCES HOLDINGS CORP effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2014 was 0.00%, a 100.00% decline from fiscal 2013.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|---|
| 2018-03-31 | -30.90% 10-Q · filed 2018-04-26 | ||
| 2017-12-31 | -57.90% 10-K · filed 2018-03-01 | ||
| 2017-03-31 | -57.70% 10-Q · filed 2018-04-26 | ||
| 2016-12-31 | -3.90% 10-K · filed 2018-03-01 | ||
| 2015-12-31 | 0.00% 10-K · filed 2018-03-01 | ||
| 2014-12-31 | 0.00% 10-K · filed 2017-02-23 | ||
| 2013-12-31 | 34.10% 10-K · filed 2015-02-27 | 43.10% 10-K · filed 2014-02-27 | |
| 2012-12-31 | 0.00% 10-K · filed 2015-02-27 | ||
| 2011-12-31 | 0.00% 8-K · filed 2014-06-20 | ||
| 2010-12-31 | -0.30% 10-K · filed 2013-02-26 | ||
| 2009-12-31 | -0.20% 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |